glp-1 ra cardiovascular benefits Incretins and disease: to the heart of type 2 diabetes? | Diabetologia GLP-1 receptor agonists and cardiorenal

Nat Genet 49(1):4653 Fomin A, Grtner A, Cyganek L, Tiburcy M, Tuleta I, Wellers L, Folsche L, Hobbach AJ, von Frieling-Salewsky M, Unger A, Hucke A, Koser F, Kassner A, Sielemann K, Streckfu-Bmeke K, Hasenfuss G, Goedel A, Laugwitz KL, Moretti A, Gummert JF, Dos Remedios CG, Reinecke H, Knll R, van Heesch S, Hubner N, Zimmermann WH, Milting H, Linke WA (2021) Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due to TTN mutations

5 ArmstrongR

With less weight to carry, women with lipedema often experience improved mobility and reduced discomfort during physical activities

Vomiting that prevents you from keeping fluids down this raises the risk of dehydration and kidney injury

Current and Pipeline GLP-1 Agonists Following the 2005 approval of exenatide for Type 2 Diabetes, there have been a series of approvals for GLP-1 agonists in both diabetes and obesity